Literature DB >> 22340357

Management of life-threatening celiac-hepatic arterial hemorrhage after pancreaticoduodenectomy: usefulness of temporary balloon occlusion.

Mao-Qiang Wang1, Li-Ping Guo, Han-Ying Lin, Feng Duan, Feng-Yong Liu, Zhi-Jun Wang.   

Abstract

When a large visceral artery is ruptured, uncontrolled bleeding may lead to hemodynamic collapse. Use of endovascular occlusion balloon catheter may provide rapid control of hemorrhage and facilitate definitive therapy. We reported two patients with massive hemorrhage from ruptured celiac-hepatic artery after pancreaticoduodenectomy, who were initially treated percutaneously by temporary selective balloon occlusion. They became critically hemodynamic unstable during the angiographic procedure. Through an 8Fr sheath, a 6Fr compliant latex occlusion balloon was placed proximal to the celiac trunk and inflated, and upon patient stabilization surgical revision and stent-graft placement were successfully performed in the two patients, respectively. Temporary selective balloon occlusion provides fast and effective bleeding control for patient with critically uncontrollable visceral arterial hemorrhage, permitting subsequent use of conventional techniques for management of the arterial bleeding source.

Entities:  

Mesh:

Year:  2011        PMID: 22340357

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  2 in total

1.  Confusing delayed hematemesis, unusual arterial hemorrhage after pancreaticoduodenectomy: a case report.

Authors:  Luna Wang; Gaoli Guo; Jianhua Yu; Ling Lin; Jianhui Yang; Baochun Lu
Journal:  J Int Med Res       Date:  2022-06       Impact factor: 1.573

2.  Heparin-bonded stent graft treatment for major visceral arterial injury after upper abdominal surgery.

Authors:  Benedikt Michael Schaarschmidt; Johannes Boos; Christian Buchbender; Patric Kröpil; Feride Kröpil; Rotem Shlomo Lanzman; Guenter Fürst; Wolfram Trudo Knoefel; Gerald Antoch; Christoph Thomas
Journal:  Eur Radiol       Date:  2018-02-26       Impact factor: 5.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.